vs
Side-by-side financial comparison of AbbVie (ABBV) and Southern Company (SO). Click either name above to swap in a different company.
AbbVie is the larger business by last-quarter revenue ($15.0B vs $8.4B, roughly 1.8× Southern Company). Southern Company runs the higher net margin — 15.9% vs 4.6%, a 11.3% gap on every dollar of revenue. On growth, AbbVie posted the faster year-over-year revenue change (9.9% vs 8.0%). Over the past eight quarters, Southern Company's revenue compounded faster (14.0% CAGR vs 1.8%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
Southern Company is an American gas and electric utility holding company based in the Southern United States. It is headquartered in Atlanta, Georgia, with executive offices located in Birmingham, Alabama. As of 2021 it is the second largest utility company in the U.S. in terms of customer base. Through its subsidiaries it serves 9 million gas and electric utility customers in 6 states. Southern Company's regulated regional electric utilities serve a 120,000-square-mile (310,000 km2) territor...
ABBV vs SO — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $15.0B | $8.4B |
| Net Profit | $697.0M | $1.3B |
| Gross Margin | — | — |
| Operating Margin | 26.6% | 24.0% |
| Net Margin | 4.6% | 15.9% |
| Revenue YoY | 9.9% | 8.0% |
| Net Profit YoY | -46.0% | 5.4% |
| EPS (diluted) | $0.39 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $15.0B | $8.4B | ||
| Q4 25 | $16.6B | $7.0B | ||
| Q3 25 | $15.8B | $7.8B | ||
| Q2 25 | $15.4B | $7.0B | ||
| Q1 25 | $13.3B | $7.8B | ||
| Q4 24 | $15.1B | $6.3B | ||
| Q3 24 | $14.5B | $7.3B | ||
| Q2 24 | $14.5B | $6.5B |
| Q1 26 | $697.0M | $1.3B | ||
| Q4 25 | $1.8B | $341.0M | ||
| Q3 25 | $186.0M | $1.7B | ||
| Q2 25 | $938.0M | $880.0M | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | $-22.0M | $466.0M | ||
| Q3 24 | $1.6B | $1.5B | ||
| Q2 24 | $1.4B | $1.2B |
| Q1 26 | — | — | ||
| Q4 25 | 72.6% | — | ||
| Q3 25 | 66.4% | — | ||
| Q2 25 | 71.8% | — | ||
| Q1 25 | 70.0% | — | ||
| Q4 24 | 70.9% | — | ||
| Q3 24 | 70.9% | — | ||
| Q2 24 | 70.9% | — |
| Q1 26 | 26.6% | 24.0% | ||
| Q4 25 | 27.3% | 13.1% | ||
| Q3 25 | 12.1% | 33.2% | ||
| Q2 25 | 31.7% | 25.3% | ||
| Q1 25 | 28.0% | 25.9% | ||
| Q4 24 | -9.9% | 16.7% | ||
| Q3 24 | 26.5% | 32.6% | ||
| Q2 24 | 27.6% | 30.0% |
| Q1 26 | 4.6% | 15.9% | ||
| Q4 25 | 10.9% | 4.9% | ||
| Q3 25 | 1.2% | 21.9% | ||
| Q2 25 | 6.1% | 12.6% | ||
| Q1 25 | 9.6% | 16.3% | ||
| Q4 24 | -0.1% | 7.3% | ||
| Q3 24 | 10.8% | 21.1% | ||
| Q2 24 | 9.5% | 18.6% |
| Q1 26 | $0.39 | — | ||
| Q4 25 | $1.02 | $0.38 | ||
| Q3 25 | $0.10 | $1.54 | ||
| Q2 25 | $0.52 | $0.79 | ||
| Q1 25 | $0.72 | $1.21 | ||
| Q4 24 | $-0.03 | $0.48 | ||
| Q3 24 | $0.88 | $1.39 | ||
| Q2 24 | $0.77 | $1.09 |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
